{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T22:08:34Z","timestamp":1788300514169,"version":"build-2803163510"},"reference-count":12,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,13]],"date-time":"2024-07-13T00:00:00Z","timestamp":1720828800000},"content-version":"vor","delay-in-days":12,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Indian Heart Journal"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.ihj.2024.07.003","type":"journal-article","created":{"date-parts":[[2024,7,14]],"date-time":"2024-07-14T08:59:43Z","timestamp":1720947583000},"page":"268-270","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Clopidogrel resistance and its effect on clinical outcomes in acute coronary syndrome"],"prefix":"10.1016","volume":"76","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8378-1441","authenticated-orcid":false,"given":"Heemanshu","family":"Lodhi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keshavamurthy Ganapathy","family":"Bhat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivek Singh","family":"Guleria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ratheesh Kumar Janardhana","family":"Pillai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ribhu","family":"Goel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nitin","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anuka","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Varun","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ihj.2024.07.003_bib1","doi-asserted-by":"crossref","DOI":"10.3390\/jpm8010008","article-title":"Pharmacogenomic impact of CYP2C19 variation on clopidogrel therapy in precision cardiovascular medicine","volume":"8","author":"Brown","year":"2018","journal-title":"J Personalized Med"},{"key":"10.1016\/j.ihj.2024.07.003_bib2","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1517\/14656566.2012.666524","article-title":"Genetic and non-genetic factors affecting the response to clopidogrel therapy","volume":"13","author":"Karazniewicz-Lada","year":"2012","journal-title":"Expet Opin Pharmacother"},{"key":"10.1016\/j.ihj.2024.07.003_bib3","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.ihj.2014.08.012","article-title":"Clopidogrel resistance: the way forward","volume":"66","author":"Ray","year":"2014","journal-title":"Indian Heart J"},{"key":"10.1016\/j.ihj.2024.07.003_bib4","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24109071","article-title":"Individualized or uniform de-escalation strategies for antiplatelet therapy in acute coronary syndrome: a Review of clinical trials with platelet function testing and genetic testing-based protocols","volume":"24","author":"El Abdallaoui","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.ihj.2024.07.003_bib5","doi-asserted-by":"crossref","first-page":"e3634","DOI":"10.1002\/jgm.3634","article-title":"Pharmacogenomic evaluation of CYP2C19 alleles linking low clopidogrel response and the risk of acute coronary syndrome in Indians","volume":"26","author":"Bhat","year":"2024","journal-title":"J Gene Med"},{"key":"10.1016\/j.ihj.2024.07.003_bib6","first-page":"5124","article-title":"Preliminary genome wide screening identifies new variants associated with coronary artery disease in Indian population","volume":"14","author":"Bhat","year":"2022","journal-title":"Am J Transl Res"},{"key":"10.1016\/j.ihj.2024.07.003_bib7","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1001\/jama.2020.12443","article-title":"Effect of genotype-guided oral P2Y12 inhibitor selection vs conventional clopidogrel therapy on ischemic outcomes after percutaneous coronary intervention: the TAILOR-PCI randomized clinical trial","volume":"324","author":"Pereira","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.ihj.2024.07.003_bib8","doi-asserted-by":"crossref","first-page":"837","DOI":"10.5114\/aoms.2018.75349","article-title":"The effect of the CYP2C19*2 allele on cardiovascular outcomes in patients with coronary artery stenting: a prospective study","volume":"15","author":"Yang","year":"2019","journal-title":"Arch Med Sci"},{"key":"10.1016\/j.ihj.2024.07.003_bib9","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.ihj.2013.10.001","article-title":"CYP 450 2C19 polymorphisms in Indian patients with coronary artery disease","volume":"66","author":"Shetkar","year":"2014","journal-title":"Indian Heart J"},{"key":"10.1016\/j.ihj.2024.07.003_bib10","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.ijcard.2016.11.217","article-title":"Pharmacodynamic and cytogenetic evaluation in CYP2C19*2 and CYP2C19*3 allelomorphism in South Indian population with clopidogrel therapy","volume":"229","author":"Tantray","year":"2017","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.ihj.2024.07.003_bib11","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1056\/NEJMoa0808227","article-title":"Genetic determinants of response to clopidogrel and cardiovascular events","volume":"360","author":"Simon","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ihj.2024.07.003_bib12","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1001\/jamacardio.2019.1510","article-title":"P2Y12 inhibitor switching in response to routine notification of CYP2C19 clopidogrel metabolizer status following acute coronary syndromes","volume":"4","author":"Povsic","year":"2019","journal-title":"JAMA Cardiol"}],"container-title":["Indian Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001948322400155X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001948322400155X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,9,20]],"date-time":"2024-09-20T12:22:03Z","timestamp":1726834923000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S001948322400155X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":12,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,7]]}},"alternative-id":["S001948322400155X"],"URL":"https:\/\/doi.org\/10.1016\/j.ihj.2024.07.003","relation":{},"ISSN":["0019-4832"],"issn-type":[{"value":"0019-4832","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clopidogrel resistance and its effect on clinical outcomes in acute coronary syndrome","name":"articletitle","label":"Article Title"},{"value":"Indian Heart Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ihj.2024.07.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Published by Elsevier, a division of RELX India, Pvt. Ltd on behalf of Cardiological Society of India.","name":"copyright","label":"Copyright"}]}}